Compare IVVD & MATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IVVD | MATH |
|---|---|---|
| Founded | 2020 | 2015 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 692.7M | 145.4M |
| IPO Year | 2021 | N/A |
| Metric | IVVD | MATH |
|---|---|---|
| Price | $2.40 | $2.75 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 12.4M | 102.6K |
| Earning Date | 11-06-2025 | 12-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | ★ $50,039,000.00 | $44,567,257.00 |
| Revenue This Year | $103.88 | N/A |
| Revenue Next Year | $171.40 | N/A |
| P/E Ratio | ★ N/A | $6.93 |
| Revenue Growth | ★ 332.71 | 165.86 |
| 52 Week Low | $0.35 | $0.99 |
| 52 Week High | $3.07 | $4.17 |
| Indicator | IVVD | MATH |
|---|---|---|
| Relative Strength Index (RSI) | 55.98 | 44.69 |
| Support Level | $2.15 | $2.84 |
| Resistance Level | $2.59 | $3.12 |
| Average True Range (ATR) | 0.18 | 0.20 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 59.80 | 40.32 |
Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.
Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and generates majority of its revenue from Hong Kong.